PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found. The finding suggests that PSAD may be an additional parameter that clinicians ...
The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...
Researchers recommend lowering it to 0.3-0.5 ng/mL per year when PSA level is below 4 ng/mL. ORLANDO—New findings presented here suggest clinicians should use a lower PSA velocity (PSAV) to recommend ...
The lexicon of PET/CT reports in prostate patients: Evaluating confidence. This is an ASCO Meeting Abstract from the 2022 ASCO Genitourinary Cancers Symposium. This abstract does not include a full ...
Health care expert and lived experience panels came to a consensus on several aspects that should be considered in the decision to offer and continue active surveillance for prostate cancer. In ...
are aged 50 and over and have asked your GP for a test Doctors also check your PSA level as you go through prostate cancer treatment. It can help them see how well treatment is working. Prostate ...
Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research. The REIMAGINE study, published today in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results